Kintara Therapeutics terminates CSO Dennis Brown; directors defer fees; CEO gets $30K/month retention

TuHURA Biosciences, Inc./NV

CSO Dennis Brown terminated effective Nov 20, 2023; will continue as consultant at ≤$350/hour month-to-month.
Board of Directors agrees to defer all director fees indefinitely to reduce costs.
CEO Robert Hoffman receives retention payment of $30,000 per month starting Nov 1, 2023.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Dennis Brown

Chief Scientific Officer

HURA · TuHURA Biosciences, Inc./NV

Effective: 2023-11-20
Filed: November 21, 2023, 6:59 PM ET

on November 20, 2023, Dennis Brown was terminated from his position as the Company’s Chief Scientific Officer, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Dennis Brown was terminated as Chief Scientific Officer at TuHURA Biosciences, Inc./NV.

Action: terminated
Role: Chief Scientific Officer

Exact text from the filing

on November 20, 2023, Dennis Brown was terminated from his position as the Company’s Chief Scientific Officer, effective immediately.

View on SEC.gov

TuHURA Biosciences, Inc./NV filing history →

Source: SEC EDGAR

accession 0000950170-23-065303

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.